New Alzheimer’s therapy restores neurotransmission
Porosome Therapeutics has shared key advancements in its disease-modifying neurological platform, which it claims will transform Alzheimer’s Disease (AD) research and treatment by offering a new approach that goes beyond symptom management. The company has demonstrated a relatively rapid reduction of the Alzheimer’s pathology in AD human… Read More